BNT-152
- Generic Name
- BNT-152
Dose Escalation Trial of BNT152+153 in Patients With Cancer
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- BioNTech SE
- Target Recruit Count
- 86
- Registration Number
- NCT04710043
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸Duke Cancer Center, Durham, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath